Please, Come Back!

Pharmalot's Ed Silverman wonders how pharmaceutical companies will deal with the impending "patent cliffs" they face that will leave them with no patent protection on their most popular drugs. One idea, he says, is to create an atmosphere of customer loyalty, emulating companies like Apple or Starbucks. Writing in BusinessWeek, consultants G.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.